These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34997211)

  • 1. Harm reduction in tobacco control: where do we draw the line?
    Al-Hamdani M; Manly E
    J Public Health Policy; 2022 Mar; 43(1):149-154. PubMed ID: 34997211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fresh look at tobacco harm reduction: the case for the electronic cigarette.
    Polosa R; Rodu B; Caponnetto P; Maglia M; Raciti C
    Harm Reduct J; 2013 Oct; 10():19. PubMed ID: 24090432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No sisyphean task: how the FDA can regulate electronic cigarettes.
    Paradise J
    Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge about E-Cigarettes and Tobacco Harm Reduction among Public Health Residents in Europe.
    Ferrara P; Shantikumar S; Cabral Veríssimo V; Ruiz-Montero R; Masuet-Aumatell C; Ramon-Torrell JM;
    Int J Environ Res Public Health; 2019 Jun; 16(12):. PubMed ID: 31212756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obsolete tobacco control themes can be hazardous to public health: the need for updating views on absolute product risks and harm reduction.
    Kozlowski LT; Abrams DB
    BMC Public Health; 2016 May; 16():432. PubMed ID: 27221096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confidence in nicotine for tobacco harm reduction-Bridging the policy-practice gap.
    Patwardhan S
    Drug Test Anal; 2023 Oct; 15(10):1205-1210. PubMed ID: 36413490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial Conflicts of Interest and Stance on Tobacco Harm Reduction: A Systematic Review.
    Hendlin YH; Vora M; Elias J; Ling PM
    Am J Public Health; 2019 Jul; 109(7):e1-e8. PubMed ID: 31095414
    [No Abstract]   [Full Text] [Related]  

  • 9. The development and testing of new nicotine replacement treatments: from 'nicotine replacement' to 'smoking replacement'.
    Hajek P
    Addiction; 2015 Jul; 110 Suppl 2():19-22. PubMed ID: 26042563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Views and Preferences for Nicotine Products as an Alternative to Smoking: A Focus Group Study of People Living with Mental Disorders.
    Meurk C; Ford P; Sharma R; Fitzgerald L; Gartner C
    Int J Environ Res Public Health; 2016 Nov; 13(11):. PubMed ID: 27886046
    [No Abstract]   [Full Text] [Related]  

  • 11. Deficiencies in public understanding about tobacco harm reduction: results from a United States national survey.
    Kiviniemi MT; Kozlowski LT
    Harm Reduct J; 2015 Jul; 12():21. PubMed ID: 26135116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harm reduction policies for tobacco users.
    Gartner C; Hall W
    Int J Drug Policy; 2010 Mar; 21(2):129-30. PubMed ID: 19944582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incentives created by a harm reduction approach to smoking cessation: Snus and smoking in Sweden and Finland.
    Maki J
    Int J Drug Policy; 2015 Jun; 26(6):569-74. PubMed ID: 25214359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Harm reduction strategy in tobacco control].
    Gorini G
    Epidemiol Prev; 2011; 35(3-4 Suppl 1):19-32. PubMed ID: 21926451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative Risk Perceptions between Snus and Cigarettes in a Snus-Prevalent Society-An Observational Study over a 16 Year Period.
    Lund KE; Vedoy TF
    Int J Environ Res Public Health; 2019 Mar; 16(5):. PubMed ID: 30862006
    [No Abstract]   [Full Text] [Related]  

  • 16. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health.
    Bates C; Fagerström K; Jarvis MJ; Kunze M; McNeill A; Ramström L
    Tob Control; 2003 Dec; 12(4):360-7. PubMed ID: 14660767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is snus the same as dip? Smokers' perceptions of new smokeless tobacco advertising.
    Bahreinifar S; Sheon NM; Ling PM
    Tob Control; 2013 Mar; 22(2):84-90. PubMed ID: 21972063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco, nicotine and harm reduction.
    Le Houezec J; McNeill A; Britton J
    Drug Alcohol Rev; 2011 Mar; 30(2):119-23. PubMed ID: 21375611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative tobacco product use and smoking cessation: a national study.
    Popova L; Ling PM
    Am J Public Health; 2013 May; 103(5):923-30. PubMed ID: 23488521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Extreme solutions for those who do not succeed to quit smoking. About smokeless tobacco and harm reduction].
    Trofor A; Eşanu V; Frăsilă EI
    Pneumologia; 2008; 57(2):105-8. PubMed ID: 18822878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.